Your browser doesn't support javascript.
loading
Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies.
Giovannoni, Gavin; Comi, Giancarlo; Rammohan, Kottil; Rieckmann, Peter; Dangond, Fernando; Keller, Birgit; Jack, Dominic; Vermersch, Patrick.
Afiliación
  • Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark St, Whitechapel, London, E1 2AT, UK. g.giovannoni@qmul.ac.uk.
  • Comi G; Casa di Cura Privata del Policlinico, Università Vita-Salute San Raffaele, Milan, Italy.
  • Rammohan K; MS Research Center, University of Miami School of Medicine, Miami, FL, USA.
  • Rieckmann P; Department of Neurology, Medical Park Loipl and University of Erlangen, Erlangen, Germany.
  • Dangond F; EMD Serono Research and Development Institute, Inc., Billerica, MA, USA.
  • Keller B; The healthcare business of Merck KGaA, Darmstadt, Germany.
  • Jack D; Merck Serono Ltd (an affiliate of Merck KGaA, Darmstadt, Germany), Feltham, UK.
  • Vermersch P; Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France.
Adv Ther ; 38(9): 4975-4985, 2021 09.
Article en En | MEDLINE | ID: mdl-34370275

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Adv Ther Asunto de la revista: TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido